• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    More On VRX.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Valeant Pharmaceuticals International, Inc. (VRX.TO)

    -Toronto
    304.44 Up 3.19(1.06%) Sep 4, 3:59PM EDT
    Add to Portfolio
    Prev Close:301.25
    Open:297.12
    Bid:303.50
    Ask:304.78
    1y Target Est:N/A
    Beta:0.788371
    Earnings Date:Oct 19 - Oct 23 (Est.)
    Day's Range:297.12 - 305.00
    52wk Range:125.50 - 347.84
    Volume:319,866
    Avg Vol (3m):444,230
    Market Cap:104.36B
    P/E (ttm):126.27
    EPS (ttm):2.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Key Statistics

    Forward P/E (1 yr):18.64
    P/S (ttm):11.16
    Ex-Dividend Date:10-Nov-10

    Analysts

    Annual EPS Est (Dec-15) :11.64
    Quarterly EPS Est (Sep-15) :2.71
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback